Patents by Inventor Kathryn Susan Prickett

Kathryn Susan Prickett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for treating polycystic ovary syndrome
    Patent number: 7960341
    Abstract: The present invention relates to methods of treating polycystic ovary syndrome (PCOS) comprising administering glucagon-like peptide-1 (GLP-1), exendin, and analogs and agonists thereof, to subjects suffering therefrom.
    Type: Grant
    Filed: September 8, 2006
    Date of Patent: June 14, 2011
    Assignee: Amylin Pharmaceuticals, Inc.
    Inventors: David R. Hathaway, Nigel Robert Arnold Beeley, Kathryn Susan Prickett, Andrew A. Young
  • NOVEL EXENDIN AGONIST COMPOUNDS
    Publication number: 20110071076
    Abstract: Novel exendin agonist compounds are provided. These compounds are useful in treating Type I and II diabetes and conditions which would benefit by lower plasma glucose and delaying and/or slowing gastric emptying.
    Type: Application
    Filed: December 2, 2010
    Publication date: March 24, 2011
    Applicant: AMYLIN PHARMACEUTICALS, INC.
    Inventors: Nigel Robert Arnold BEELEY, Kathryn Susan Prickett
  • Novel exendin agonist compounds
    Publication number: 20080119393
    Abstract: Novel exendin agonist compounds are provided. These compounds are useful in treating diabetes and conditions which would be benefited by lowering plasma glucose or delaying and/or slowing gastric emptying.
    Type: Application
    Filed: May 25, 2007
    Publication date: May 22, 2008
    Applicant: Amylin Pharmaceuticals, Inc.
    Inventors: Nigel Robert Arnold Beeley, Kathryn Susan Prickett
  • Exendin agonist compounds
    Patent number: 7223725
    Abstract: The present invention relates to novel exendin agonist compounds useful in treatment of Type I and II diabetes, and useful in lowering plasma glucose levels, reducing body weight, and delaying and/or slowing gastric emptying.
    Type: Grant
    Filed: November 13, 1998
    Date of Patent: May 29, 2007
    Assignee: Amylin Pharmaceuticals, Inc.
    Inventors: Nigel Robert Arnold Beeley, Kathryn Susan Prickett
  • Exendin agonist compounds
    Patent number: 7157555
    Abstract: Novel exendin peptide compounds are provided.
    Type: Grant
    Filed: August 6, 1998
    Date of Patent: January 2, 2007
    Assignee: Amylin Pharmaceuticals, Inc.
    Inventors: Nigel Robert Arnold Beeley, Kathryn Susan Prickett